Barriers to Drug Delivery in Solid Tumors

1994/07/01 by Rakesh K. Jain · 1,073 citations
Materials Science · Medicine · #Cancer #Drug #Drug delivery #Internal medicine #Materials science #Medicine #Nanoparticle-Based Drug Delivery #Nanotechnology #Pharmacology #Solid tumor

paper · doi:10.1038/scientificamerican0794-58

published in Scientific American 271(1), 58-65 (Springer Nature)

openalex publication_date 1994/07/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/25

Cited by

• Modeling and Analysis of a Virus that Replicates Selectively in Tumor Cells
• Effect of heterogeneous vasculature on interstitial transport within a solid tumor
• Asymptotic stability of spatial homogeneity in a haptotxis model for oncolytic virotherapy
• Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
• Dampening effect of logistic source in a two-dimensional haptotaxis system with nonlinear zero-order interaction
• Pressure-Enabled Drug Delivery Significantly Increases Intra-Arterial Delivery of Embolic Microspheres to Liver Tumors in a Porcine Model
• Morphology transitions induced by chemotherapy in carcinomasin situ
• Drug penetration in solid tumours
• Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier-Mediated Anticancer Agents
• Nonlinear Partial Differential Equations with Applications
• Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. [europepmc]
• Polymer-drug conjugates: recent development in clinical oncology. [europepmc]
• Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. [europepmc]
• Imaging angiogenesis and the microenvironment. [europepmc]
• Peptide-based Biopolymers in Biomedicine and Biotechnology. [europepmc]
• Biology of angiogenesis and invasion in glioma. [europepmc]
• Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease. [europepmc]
• Circumventing tumor resistance to chemotherapy by nanotechnology. [europepmc]
• Engineering RNA for targeted siRNA delivery and medical application. [europepmc]
• Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. [europepmc]
• The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors. [europepmc]
• Delivering nanomedicine to solid tumors. [europepmc]
• Intratumoral drug delivery with nanoparticulate carriers. [europepmc]
• Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys. [europepmc]
• Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. [europepmc]
• Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. [europepmc]
• Progress in microRNA delivery. [europepmc]
• Delivery of molecular and cellular medicine to solid tumors. [europepmc]
• Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery. [europepmc]
• Design considerations for nanotherapeutics in oncology. [europepmc]
• Mechanical Forces in Tumor Angiogenesis. [europepmc]
• Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma. [europepmc]
• Nanoscale Bacteria-Enabled Autonomous Drug Delivery System (NanoBEADS) Enhances Intratumoral Transport of Nanomedicine. [europepmc]
• Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. [europepmc]
• STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. [europepmc]